NCT07700745Active, not recruiting
A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
This is a single-arm, open-label, decentralized (fully remote) clinical trial evaluating the tolerability and self-perceived skin effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in 35 adults aged 18-65 with self-reported eczema-prone skin. Participants will use the body wash once daily in place of their usual cleanser, followed by the Skin Recovery Cream, for 4 consecutive weeks.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- First submitted
- 7 Jul 2026
- Start date
- Jul 2026
- Primary completion date
- Aug 2026
- Lead sponsor
- Rejuvaskin
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07700745
What you commit to
- Study type: Interventional
- Planned participants: 35
- From Jul 2026 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently using prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical eczema treatments on the body, or initiation of such treatment planned during the study.
Other illness
- Known allergy or sensitivity to any ingredient in the study product.
- Active, severe skin condition on the body requiring prescription topical or systemic treatment (e.g., active severe atopic dermatitis flare under medical care, active infection at intended application sites).
Other
- Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
- Currently participating in another clinical or skincare research study, or planning to enroll during this study's duration. (
Who the study is looking for
- Adult women or men aged 18-65 years.
- Self-reported symptoms of eczema or eczema-prone skin (e.g., dryness, roughness, itching, irritation on the body).
- Visible signs of eczema such as dryness, roughness, or irritation on at least one part of the body at the time of enrollment.
- Willing to use Rejuvaskin Eczema Body Wash once daily as their primary body cleanser for 4 consecutive weeks.
- Willing to use Rejuvaskin Skin Recovery Cream once daily after using the - Rejuvaskin body cleanser for 4 consecutive weeks.
- Willing to maintain their current diet, skincare routine (aside from substitution of body wash and skin cream), and lifestyle habits for the study duration.
- Willing and able to take standardized photographs of an affected body area at Baseline and Week 4 using a personal smartphone.
- Able to read, understand, and complete questionnaires in English.
- Resides in the United States with a valid shipping address.
- Willing to provide informed consent and comply with all study procedures
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Citruslabs Coordinator of this site? Confirm its status | Las Vegas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.